title: Sox2 enhances the tumorigenicity and chemoresistance of cancer stem-like cells derived from gastric cancer.
abstract: Gastric cancer stem-like cells (GCSCs) have been identified to possess the ability of self-renewal and tumor initiation. However, the mechanisms involved remain largely unknown. Here, we isolated and characterized the GCSCs by side population (SP) sorting procedure and cultured sphere cells (SC) from human gastric cancer cell lines SGC-7901, BGC-823, MGC-803, HGC-27 and MKN-28. The sorting and culture assay revealed that SP cells proliferated in an asymmetric division manner. In addition, SP cells exhibited a higher potential of spheroid colony formation and greater drug resistance than non-SP cells (NSP). Moreover, the SC were found with enhanced capabilities of drug resistance in vitro and tumorigenicity in vivo. Sox2 mRNA and protein was highly and significantly overexpressed in the SP cells and SC. Importantly, downregulation of Sox2 with siRNA obviously reduced spheroid colony formation and doxorubicin efflux, as well as increased apoptosis rate in sphere cells in vitro and suppressed tumorigenicity in vivo. These results suggest that both SP cells and cultured SC enrich with GCSCs and that Sox2 plays a pivotal role in sustaining stem cell properties and might be a potential target for gastric cancer therapy.
authors.affiliation: Department of Cell Biology, Cancer Center, Nanjing Medical University, Nanjing, Jiangsu 210029, China;
authors.forename: Tian
authors.initials: T
authors.lastname: Tian
authors.forename: Yajie
authors.initials: Y
authors.lastname: Zhang
authors.forename: Shouyu
authors.initials: S
authors.lastname: Wang
authors.forename: Jianwei
authors.initials: J
authors.lastname: Zhou
authors.forename: Shan
authors.initials: S
authors.lastname: Xu
keywords: CD44; Sox2; chemoresistance; gastric cancer stem-like cells; side population
references.citation: Nat Med. 2001 Sep;7(9):1028-34
references.pmid: 11533706
references.citation: Cell. 2005 Sep 23;122(6):947-56
references.pmid: 16153702
references.citation: Blood. 2000 Aug 1;96(3):902-9
references.pmid: 10910903
references.citation: Cancer Res. 2005 Jul 15;65(14):6207-19
references.pmid: 16024622
references.citation: Br J Cancer. 2008 Feb 26;98(4):824-31
references.pmid: 18268498
references.citation: J Surg Res. 2012 May 1;174(1):130-5
references.pmid: 21227461
references.citation: Cancer Sci. 2009 Aug;100(8):1397-402
references.pmid: 19493275
references.citation: Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi. 2006 Apr;24(4):205-8
references.pmid: 16701030
references.citation: Nature. 2007 Jan 4;445(7123):106-10
references.pmid: 17122772
references.citation: Genes Dev. 2003 Jan 1;17(1):126-40
references.pmid: 12514105
references.citation: Appl Immunohistochem Mol Morphol. 2010 Jan;18(1):55-61
references.pmid: 19661786
references.citation: Blood. 2002 Jan 15;99(2):507-12
references.pmid: 11781231
references.citation: Nature. 2006 Dec 7;444(7120):756-60
references.pmid: 17051156
references.citation: Carcinogenesis. 2008 Dec;29(12):2289-97
references.pmid: 18820285
references.citation: Br J Cancer. 2008 Jan 29;98(2):380-7
references.pmid: 18219291
references.citation: Dev Neurosci. 2004 Mar-Aug;26(2-4):148-65
references.pmid: 15711057
references.citation: Stem Cells. 2012 Jun;30(6):1064-75
references.pmid: 22415968
references.citation: Br J Cancer. 2011 Apr 26;104(9):1410-7
references.pmid: 21468047
references.citation: Ann Surg Oncol. 2012 Apr;19(4):1357-64
references.pmid: 21523522
references.citation: Int J Oncol. 2009 May;34(5):1201-7
references.pmid: 19360333
references.citation: Nat Rev Cancer. 2005 Apr;5(4):275-84
references.pmid: 15803154
references.citation: Nature. 2007 Jan 4;445(7123):111-5
references.pmid: 17122771
references.citation: Stem Cells. 2009 Jan;27(1):40-8
references.pmid: 18948646
references.citation: Nat Rev Cancer. 2008 Oct;8(10):755-68
references.pmid: 18784658
references.citation: Cancer Lett. 2011 Nov 1;310(1):46-52
references.pmid: 21782323
references.citation: Tumori. 2011 May-Jun;97(3):393-9
references.pmid: 21789022
references.citation: Cancer Res. 2009 Feb 15;69(4):1302-13
references.pmid: 19190339
references.citation: Oncogene. 2012 Feb 9;31(6):671-82
references.pmid: 21743497
references.citation: Cell Mol Life Sci. 2011 Nov;68(21):3589-605
references.pmid: 21448722
references.citation: Stem Cells. 2006 Mar;24(3):506-13
references.pmid: 16239320
references.citation: Proc Natl Acad Sci U S A. 2004 Sep 28;101(39):14228-33
references.pmid: 15381773
references.citation: Cell Res. 2012 Jan;22(1):248-58
references.pmid: 21727908
references.citation: Cancer Res. 2007 Apr 15;67(8):3716-24
references.pmid: 17440084
references.citation: Nat Rev Cancer. 2003 Aug;3(8):592-600
references.pmid: 12894247
references.citation: Proc Natl Acad Sci U S A. 2007 Oct 9;104(41):16158-63
references.pmid: 17911267
references.citation: Cell Stem Cell. 2009 Mar 6;4(3):226-35
references.pmid: 19265662
references.citation: Pathol Oncol Res. 2011 Dec;17(4):939-46
references.pmid: 21553350